Goldman Sachs’s Viridian Therapeutics VRDN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$12.6M Sell
899,825
-331,267
-27% -$4.63M ﹤0.01% 2101
2025
Q1
$16.6M Buy
1,231,092
+310,998
+34% +$4.19M ﹤0.01% 1843
2024
Q4
$17.6M Buy
920,094
+180,841
+24% +$3.47M ﹤0.01% 1883
2024
Q3
$16.8M Sell
739,253
-260,688
-26% -$5.93M ﹤0.01% 1858
2024
Q2
$13M Buy
999,941
+456,801
+84% +$5.94M ﹤0.01% 1902
2024
Q1
$9.51M Buy
543,140
+161,403
+42% +$2.83M ﹤0.01% 2080
2023
Q4
$8.31M Sell
381,737
-17,543
-4% -$382K ﹤0.01% 2223
2023
Q3
$6.12M Buy
399,280
+83,723
+27% +$1.28M ﹤0.01% 2330
2023
Q2
$7.51M Sell
315,557
-39,353
-11% -$936K ﹤0.01% 2264
2023
Q1
$9.03M Buy
354,910
+111,236
+46% +$2.83M ﹤0.01% 2089
2022
Q4
$7.12M Sell
243,674
-126,054
-34% -$3.68M ﹤0.01% 2367
2022
Q3
$7.58M Buy
+369,728
New +$7.58M ﹤0.01% 2337
2022
Q2
Sell
-66,598
Closed -$1.23M 5867
2022
Q1
$1.23M Buy
+66,598
New +$1.23M ﹤0.01% 3957
2020
Q4
Sell
-3,420
Closed -$40K 4768
2020
Q3
$40K Hold
3,420
﹤0.01% 4343
2020
Q2
$57K Hold
3,420
﹤0.01% 4244
2020
Q1
$23K Sell
3,420
-125
-4% -$841 ﹤0.01% 4345
2019
Q4
$26K Sell
3,545
-14,872
-81% -$109K ﹤0.01% 4246
2019
Q3
$202K Sell
18,417
-18,042
-49% -$198K ﹤0.01% 3914
2019
Q2
$1.12M Buy
36,459
+31,782
+680% +$977K ﹤0.01% 3124
2019
Q1
$196K Buy
4,677
+744
+19% +$31.2K ﹤0.01% 3901
2018
Q4
$179K Buy
3,933
+1,398
+55% +$63.6K ﹤0.01% 3771
2018
Q3
$212K Sell
2,535
-534
-17% -$44.7K ﹤0.01% 3803
2018
Q2
$295K Sell
3,069
-1,378
-31% -$132K ﹤0.01% 3734
2018
Q1
$468K Buy
+4,447
New +$468K ﹤0.01% 3529
2017
Q3
Sell
-8,146
Closed -$1.58M 4416
2017
Q2
$1.58M Buy
8,146
+3,823
+88% +$742K ﹤0.01% 2918
2017
Q1
$807K Buy
+4,323
New +$807K ﹤0.01% 3229
2016
Q2
Sell
-54
Closed -$6K 4649
2016
Q1
$6K Buy
+54
New +$6K ﹤0.01% 4461